Insider Transactions in Q1 2022 at Eye Point Pharmaceuticals, Inc. (EYPT)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 14
2022
|
Michael Craig Pine Chief Corp Dev.&Strat. Officer |
BUY
Open market or private purchase
|
Direct |
1,000
+50.0%
|
$12,000
$12.21 P/Share
|
|
Feb 28
2022
|
Nancy Lurker |
BUY
Exercise of conversion of derivative security
|
Direct |
12,466
+7.66%
|
-
|
|
Feb 28
2022
|
Dario A. Paggiarino Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,294
-6.49%
|
$11,646
$9.95 P/Share
|
|
Feb 28
2022
|
Dario A. Paggiarino Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,105
+17.07%
|
-
|
|
Feb 28
2022
|
David Scott Jones SVP & Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,130
-6.75%
|
$10,170
$9.95 P/Share
|
|
Feb 28
2022
|
David Scott Jones SVP & Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,105
+19.7%
|
-
|
|
Feb 21
2022
|
Nancy Lurker |
BUY
Exercise of conversion of derivative security
|
Direct |
13,717
+9.05%
|
-
|
|
Feb 09
2022
|
Nancy Lurker |
BUY
Exercise of conversion of derivative security
|
Direct |
17,533
+12.38%
|
-
|
|
Feb 09
2022
|
David Scott Jones SVP & Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,473
-10.45%
|
$14,730
$10.13 P/Share
|
|
Feb 09
2022
|
David Scott Jones SVP & Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,966
+26.05%
|
-
|
|
Feb 09
2022
|
Dario A. Paggiarino Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,721
-9.8%
|
$17,210
$10.13 P/Share
|
|
Feb 09
2022
|
Dario A. Paggiarino Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,966
+22.04%
|
-
|
|
Feb 09
2022
|
Jay S. Duker President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
4,966
+31.86%
|
-
|
|
Feb 09
2022
|
George Elston Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,721
-15.2%
|
$17,210
$10.13 P/Share
|
|
Feb 09
2022
|
George Elston Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,966
+30.49%
|
-
|
|
Feb 09
2022
|
Goran Ando |
BUY
Exercise of conversion of derivative security
|
Direct |
2,750
+35.95%
|
-
|
|
Feb 09
2022
|
Wendy F Dicicco |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+36.23%
|
-
|
|
Feb 09
2022
|
David R Guyer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+36.23%
|
-
|
|
Feb 09
2022
|
John B. Landis |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+22.94%
|
-
|